9 results match your criteria: "Karolinska Institutet at Danderyd Hospital (KIDS)[Affiliation]"
Anaesthesiol Intensive Ther
October 2024
Karolinska Institutet at Danderyd Hospital (KIDS), Stockholm, Sweden.
Int J Obstet Anesth
February 2024
Karolinska Institutet at Danderyd Hospital (KIDS), Stockholm, Sweden. Electronic address:
Background: Hypovolemia and peripheral edema are frequent components of preeclampsia. The level of the dysregulation of the body fluid distribution is unclear, which complicates the choice of infusion fluid during surgery. The present fluid kinetic study challenges whether the maldistribution of fluid is due to increased capillary leakage or to poor return of already distributed fluid, which occurs via lymphatic pathways.
View Article and Find Full Text PDFMicrovasc Res
July 2023
Karolinska Institutet at Danderyd Hospital (KIDS), Stockholm, Sweden. Electronic address:
Background: Intravenous infusion of hyper-oncotic 20 % albumin expands the plasma volume by approximately twice the infused volume. We investigated whether the recruited fluid stems from accelerated flow of efferent lymph, which would add protein to the plasma, or from reversed transcapillary solvent filtration, where the solvent is expected to be low in protein.
Methods: We analyzed data from 27 intravenous infusions of 20 % albumin (3 mL/kg; approximately 200 mL) over 30 min given to 27 volunteers and patients.
Acta Anaesthesiol Scand
February 2023
Karolinska Institutet at Danderyd Hospital (KIDS), Karolinska institutet, Stockholm, Sweden.
Pediatr Crit Care Med
December 2021
Department of Women's and Children's Health, Uppsala University and Pediatric Oncology, Uppsala University Hospital, Uppsala, Sweden.
Objectives: Despite progress in the treatment of childhood acute lymphoblastic leukemia, severe complications are common, and the need of supportive care is high. We explored the cumulative prevalence, clinical risk factors, and outcomes of children with acute lymphoblastic leukemia, on first-line leukemia treatment in the ICUs in Sweden.
Design: A nationwide prospective register and retrospective chart review study.
J Pediatr Hematol Oncol
March 2021
Department of Women's and Children's Health, Uppsala University.
Background: Extracorporeal membrane oxygenation (ECMO) is used in severe respiratory and/or circulatory failure when conventional critical care fails. Studies on patients with hematologic malignancies on ECMO have shown contradictory results; immunosuppression and coagulopathy are relative contraindications to ECMO.
Observations: This nationwide Swedish retrospective chart review identified 958 children with hematologic malignancies of whom 12 (1.
Acta Paediatr
April 2019
Department of Paediatric Anaesthesia, Intensive Care and ECMO Services, Astrid Lindgren Children's Hospital, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden.
Aim: To investigate whether unnecessary harm could be avoided in children admitted to paediatric intensive care (PICU), we analysed the impact of arterial blood gas on the paediatric index of mortality score2 (PIM2) and the derived predicted death rate (PDR).
Methods: From January 1, 2008 to December 31, 2010, 1793 consecutive admissions, newborn infants to 16 years of age (median 0.71 years) from a single, tertiary PICU in Gothenburg Sweden, were collected.
PLoS One
July 2018
Department of Anaesthesia and Intensive Care at Danderyd Hospital, Karolinska Institutet at Danderyd Hospital (KIDS), Stockholm, Sweden.
Objective: Factors predicting survival over time after pediatric intensive care unit (PICU) admissions are not fully understood. The primary aim of the current study was to investigate whether multiple admissions (MADM) compared to single PICU admissions (SADM) were associated with poor survival over time after being admitted to PICU facilities. Our secondary aim was to investigate if the presence of a complex chronic condition (CCC) would further impair prognosis.
View Article and Find Full Text PDFJ Eur Acad Dermatol Venereol
March 2017
Department of Dermatology, Donauspital, University affiliated Hospital, Vienna, Austria.
Cutaneous lupus erythematosus (CLE) is a rare inflammatory autoimmune disease with heterogeneous clinical manifestations. To date, no therapeutic agents have been licensed specifically for patients with this disease entity, and topical and systemic drugs are mostly used 'off-label'. The aim of the present guideline was to achieve a broad consensus on treatment strategies for patients with CLE by a European subcommittee, guided by the European Dermatology Forum (EDF) and supported by the European Academy of Dermatology and Venereology (EADV).
View Article and Find Full Text PDF